Pan-resistant Candida auris isolates from the outbreak in New York are susceptible to ibrexafungerp (a glucan synthase inhibitor)

Subjects

Subjects :

Microbiology (medical)
Cross Infection
Antifungal Agents
business.industry
Candidiasis
New York
Outbreak
Microbial Sensitivity Tests
General Medicine
Triterpenes
Disease Outbreaks
Microbiology
Infectious Diseases
Candida auris
Glucosyltransferases
Drug Resistance, Multiple, Fungal
Humans
Medicine
Pharmacology (medical)
Glucan synthase
Glycosides
business
Candida

Details

ISSN :

09248579

Volume :

55

Database :

OpenAIRE

Journal :

International Journal of Antimicrobial Agents

Accession number :

edsair.doi.dedup.....690f56c57996aa1c1803a7f14957664a